Trials / Completed
CompletedNCT03193957
An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis
An Open-label, Single-arm, Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Samsung Bioepis Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
A study comparing the usability of the Autoinjector and Pre-filled Syringe of SB4 in Subjects with Rheumatoid Arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | Etanercept PFS and Autoinjector |
| DEVICE | Autoinjector | Autoinjector |
Timeline
- Start date
- 2017-05-15
- Primary completion
- 2017-08-03
- Completion
- 2017-09-25
- First posted
- 2017-06-21
- Last updated
- 2017-10-13
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03193957. Inclusion in this directory is not an endorsement.